Velsera's Innovative Tumor Profiling Technology Receives Approval
Transforming Cancer Diagnostics through Innovation
Velsera, a prominent player in healthcare technology, is thrilled to announce a significant milestone in cancer diagnostics. The company’s advanced tumor profiling technology plays a crucial role in the Illumina TruSight™ Oncology Comprehensive in vitro diagnostic (IVD) results report. By merging its extensive knowledge base with tumor profiling expertise, Velsera enhances patient care and paves the way for personalized treatment across the nation.
Partnership with Illumina
The collaboration between Velsera and Illumina was born out of a shared commitment to advance cancer diagnostics and improve access to targeted therapeutics. Since it began in late 2018, this partnership has evolved into a vital alliance for the healthcare community. Velsera's Knowledge Base (KB) is essential in the TSO Comprehensive test, streamlining the adoption of next-generation sequencing (NGS)-based diagnostics for laboratories.
Impact on Cancer Treatment
According to Nicki Berry, Head of Region-Americas at Illumina, the collaboration has been instrumental in delivering the Vision for the TruSight™ Oncology Comprehensive test. This NGS-based test simplifies the identification of key cancer biomarkers, promoting better clinical decisions.
Enhancing Patient Outcomes
Velsera's Knowledge Base content plays a vital role in determining the clinical significance of cancer mutations. This advancement leads to personalized and effective treatment plans tailored to individual patient needs. Jamie Littlejohns, CEO of Velsera, emphasizes the company's commitment to making targeted therapeutics accessible to healthcare systems and patients worldwide. The latest achievement highlights their drive to translate research discoveries into significant improvements in patient outcomes.
Advancing Precision Medicine
As precision medicine continues to evolve, Velsera is positioned as a leader, collaborating with industry giants like Illumina to reshape the diagnostics landscape. This commitment aims to accelerate the market entry of IVD solutions, setting new standards for sequencing technologies and ensuring faster and more accurate biomarker identification, which greatly enhances patient care.
About Velsera
Founded in 2023 from the merger of Seven Bridges, PierianDx, and UgenTec, Velsera is on a mission to be the go-to platform for discovery, evidence generation, and clinical delivery in precision medicine. The company operates in key regions including Europe and Asia, helping professionals make informed decisions about delivering the right therapy at the right time to patients.
Contact Information
For inquiries, please contact:
Brian Lassiter
Manager, Commercial Marketing
Velsera
(857) 357-3060 | ext 3060
Frequently Asked Questions
What is Velsera's role in cancer diagnostics?
Velsera provides advanced tumor profiling technology that enhances the Illumina TruSight Oncology Comprehensive IVD, integrating data for improved patient treatment.
How does the partnership with Illumina affect cancer treatment?
The partnership allows for the development of an NGS-based test that simplifies the identification of important cancer biomarkers, ultimately leading to better clinical outcomes.
What is the impact of Velsera's Knowledge Base?
Velsera's Knowledge Base aids in classifying cancer mutations, helping clinicians create personalized treatment plans based on the clinical significance of these mutations.
What advances has Velsera made in precision medicine?
Velsera has positioned itself as a leader in precision medicine by accelerating the development and accessibility of innovative diagnostic solutions for cancer care.
How can I contact Velsera for more information?
You can reach Brian Lassiter, Manager of Commercial Marketing, at (857) 357-3060 for inquiries about Velsera's services and offerings.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Discover VOOPOO's Innovative Vaping Experience at InterTabac
- Asia-Pacific Judges Collaborate in Innovative Masterclass Program
- Credo Technology Reports Remarkable Growth and Insider Sales
- Marvell Technology Director's $6.8 Million Stock Sale: Insights
- Itron Showcases Innovative Smart City Solutions in Indonesia
- Michael Michail's Innovative Xpress Harder Iced Tea Launch
- Signing Day Sports CEO Receives $100K High-Interest Note
- Intel's Innovative Shift: Launching a Separate Foundry Unit
- Innovative Shared-Use Kitchen Launches to Help Local Entrepreneurs
- Marvell Technology Confirms Board Member's Departure and Future Focus
Recent Articles
- Pit Crew Roofing Empowers Education Through Community Support
- Mastering Leadership: Insights from Leslie A. Rubin's Expertise
- Annex Brands Expands with New PostalAnnex Store Opening
- Exciting Spring Break Destinations for 2025 Revealed by STS Travel
- Exciting Prizes Await at Bloomsburg Fair with MDi Built
- Emotional Premiere of 'Tears' Short Film at Music Festival
- VIVA Creative Takes Center Stage at Inaugural Congressional Event
- Join Kit NA Brewing's Empowering Sober October Initiative
- Nuvalent Sees Promising Future with Analyst Upgrades and Trials
- Donegal Group Insider Transaction Signals Investor Confidence
- General Mills Outlook Brightens as Citi Boosts Price Target
- BTIG Holds Neutral Outlook on Global Net Lease Amid Asset Sales
- Stifel's New Price Target Signals Optimism for RH Growth
- Complete Solar Set to Expand through Acquisition of SunPower Assets
- Tactile Medical's Nimbl System Secures Medicare Billing Approval
- Aethlon Medical Advances Cancer Treatment With Hemopurifier
- Allarity Therapeutics Achieves Milestone in Ovarian Cancer Trial
- Mizuho Maintains Neutral Outlook on Apellis Pharmaceuticals
- Citi Shifts Strategy: Downgrades on Semiconductor Stocks Amid Risks
- Navigating Bullish and Bearish Trends in E-Mini Futures Market
- Medigene’s R&D Event on 3S TCRs: A Path to Cancer Treatment
- Biodexa Pharmaceuticals Unlocks $17 Million CPRIT Grant Funding
- Kairous Acquisition Corp. Enhances Trust Account for Business Deal
- Join Jet.AI's Upcoming Shareholder Webinar This Thursday
- Transforming Homes: Smart Automation Market Set to Surge
- Cognitive Computing Market Transformation: Forecasts and Trends
- Electric Vehicle Surge Fuels Automotive Electronics Market Growth
- Growth Projections for Compression Therapy Industry Through 2031
- Barley Market Growth and Innovation Trends Forecast to 2032
- A Comprehensive Disclosure by Rathbones Group on Keywords Studios
- Veea Inc. and Plum Acquisition Corp. I Complete Major Merger
- Chanson International Holding's Milestone Public Offering Details
- Inside the Innovations of SMC Entertainment’s CEO Erik Blum
- InterDigital's Innovative Video Technologies Earn Prestigious Awards
- Clene Engages FDA to Discuss Innovative ALS Treatment Strategies
- Kratos Achieves Landmark Test Success for Innovative Engine
- Exploring the Breakthrough Success of Merit Medical's WRAPSODY Trial
- BIGG Digital Assets Inc. Announces TSX Venture Listing
- Cellebrite Launches Enhanced Cloud-Based Investigative Analytics
- Exciting Collaboration: Metavesco Teams with Local Choice Spirits
- Complete Solar Emerges Victorious in SunPower Asset Acquisition
- Rathbones Group and Balanced Commercial Property Trust Update
- Bitdeer Technologies Unveils $150 Million Funding Strategy
- Explore the Top Forex Brokers for South African Traders
- Top Consumer Stocks with Impressive Dividends Revealed
- Insider Trades: Netflix, Dell, and Other Key US Companies
- Simply Better Brands Expands TRUBAR Distribution at Walmart
- DeFi Technologies Moves Forward with SEC Registration Filing
- IceCure Medical's ProSense® Shows Promising Effectiveness in Oncology
- ChargePoint Welcomes David Vice as New Chief Revenue Officer